Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Disc Medicine, Inc. Banner

Disc Medicine, Inc.

IRON Stock Analysis

Page title

Section title

About Disc Medicine, Inc.

Biotechnology
Healthcare

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Disc Medicine, Inc. Key Metrics

Market Cap
$1B
52 Weeks Low
$25.60
52 Weeks High
$77.60
P/B
2.50x
P/E
-13.43x
P/S
0x

Upcoming Events

    IRON Analyst Forecasts

    ‌
    ‌

    IRON Financials

    IRON Income Statement Key Metrics

    • Revenue(TTM)0
    • Gross Profit(TTM)-76,000
    • EBITDA(TTM)-110.80 M
    • Net Income(TTM)-91.00 M
    • EPS Diluted(TTM)-3.7

    Decode IRON's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    IRON earnings and revenue history

    IRON Return on Equity

    See how efficiently IRON generates profit for it's shareholders.

    -22.15%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of IRON (-0.221) is higher than the average of its peers (-0.331).

    Return on Equity Growth

    IRON's Return on Equity has shown poor growth over the past 10 years, increasing by only -14.08%.

    IRON Revenue Growth

    See how IRON has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    IRON's revenue has shown poor growth over the past 10 years, increasing by only 0%.